| Market Cap | ₹44Cr |
| ROE | 8.41% |
| P/E Ratio(TTM) | 12.48 |
| EPS(TTM) | 1.07 |
| P/B Ratio | 1.04 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.69 |
| Book Value | 12.78 |
| Debt to Equity | 0.27 |
| Face Value | 10 |
| Parent Organisation | Jfl Life Sciences |
| Managing Director | SMIRAL ASHWINKUMAR PATEL |
| Founded | 2010 |
| NSE Symbol | JFLLIFE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.10 | ||
| Ajanta Pharma | NA (0.00%) | 33.65 | ||
| Gland Pharma | NA (0.00%) | 34.84 | ||
| Eris Lifesciences | NA (0.00%) | 47.73 |